Jane Henley, MSPH
Jane Henley is an epidemiologist in the Cancer Surveillance Branch in the Division of Cancer Prevention and Control at CDC. Ms. Henley joined CDC in 2010 and uses data from CDC’s National Program of Cancer Registries and other surveillance systems to monitor cancer outcomes. Before coming to CDC, she worked as an epidemiologist at the American Cancer Society in the analytic epidemiology program and conducted analyses using data from the Cancer Prevention Study cohorts.
Her research interests include surveillance of cancers linked to modifiable risk factors, including tobacco use, alcohol use, physical activity, and obesity. She has contributed to more than 100 journal articles and book chapters, including publications about cancer surveillance; rare cancers including mesothelioma; lung cancer and other tobacco-related cancers; health consequences of cigarette, cigar, pipe, and smokeless tobacco use; and health benefits of smoking cessation. She has lectured on the use of population-based cancer registry data in cancer prevention and control at Emory University and lung cancer at the Morehouse School of Medicine.
Ms. Henley earned an undergraduate degree in statistics from Mount Holyoke College and a master of science in public health in biostatistics from the Rollins School of Public Health, Emory University.
Articles Ms. Henley has first-authored include—
- 2020 Annual report to the nation on the status of cancer, part I: National cancer statistics.
- 2020 Annual report to the nation on the status of cancer, part II: progress toward Healthy People 2020 objectives for 4 common cancers.
- 2019 Smoking cessation behaviors among older adults.
- 2019 Geographic co-occurrence of mesothelioma and ovarian cancer incidence, United States 2003–2015.
- 2018 Uterine cancer incidence and mortality—United States, 1999–2016.
- 2018 Rural cancer control: Bridging the chasm in geographic health inequity.
- 2018 A Report from CDC: Lung cancer among women in the United States.
- 2017 Invasive cancer incidence, 2004–2013, and deaths, 2006–2015, in nonmetropolitan and metropolitan counties—United States.
- 2017 Invasive cancer incidence and survival—United States, 2013.
- 2016 Vital Signs: Disparities in tobacco-related cancer incidence and mortality—United States, 2004–2013.
- 2015 Invasive cancer incidence and survival—United States 2012.
- 2015 Gallbladder cancer incidence and mortality, United States, 1999–2011.
- 2015 Invasive cancer incidence and survival—United States, 2011.
- 2014 Health consequences of smokeless tobacco use. [PDF-1.2MB] In: Hatsukami DK, Zeller M, Gupta P, Parascandola M, Asma S, eds. Smokeless tobacco and public health: a global perspective.
- 2014 Alcohol control efforts in comprehensive cancer control plans and alcohol use among adults in the USA.
- 2014 Invasive cancer incidence—United States, 2010.
- 2014 Lung cancer incidence trends among men and women, United States, 2005–2009.
- 2013 Mesothelioma incidence in 50 states and District of Columbia, United States, 2003–2008.
- 2011 State-specific trends in lung cancer incidence and smoking—United States, 1999–2008.
- 2010 Surveillance of screening-detected cancers (colon and rectum, breast, cervix)—United States, 2004–2006.
- 2007 Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco.
- 2006 Response to Foulds J and Ramstrom L letter regarding “Causal effects of smokeless tobacco on mortality in CPS-I and CPS-II” (letter).
- 2005 Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States).
- 2004 Association between exclusive pipe smoking and mortality from cancer and other diseases.
- 2002 Leanness and lung cancer risk: fact or artifact?
- 2001 Use of permanent hair dyes and bladder-cancer risk.